Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells

Yann Duchartre1, Yong-Mi Kim1, Michael Kahn2,3

  • 1Division of Hematology and Oncology, Department of Pediatrics and Pathology, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Insights

Wnt signaling controls cell renewal in stem cells and cancer. Targeting this pathway in diseases remains difficult, but new therapeutic strategies are emerging for Wnt pathway dysregulation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Wnt signaling is crucial for self-renewal in normal somatic and cancer stem cells.
  • Dysregulated Wnt signaling is implicated in numerous cancers and diseases.
  • Despite advances, effectively targeting the Wnt pathway therapeutically is challenging.

Purpose of the Study:

  • To review recent therapeutic strategies targeting the Wnt signaling pathway.
  • To highlight preclinical and clinical approaches for Wnt pathway-associated diseases.

Main Methods:

  • Literature review of preclinical studies.
  • Analysis of clinical trial data.
  • Synthesis of recent research on Wnt pathway therapeutics.

Main Results:

  • Several therapeutic strategies targeting the Wnt pathway have shown promise in preclinical models.
  • Early-phase clinical trials are investigating Wnt inhibitors for various malignancies.
  • The review consolidates current knowledge on the therapeutic landscape of Wnt signaling.

Conclusions:

  • Targeting Wnt signaling represents a promising therapeutic avenue for cancer and other diseases.
  • Continued research and clinical investigation are essential to overcome challenges in Wnt pathway-targeted therapy.
  • Developing effective Wnt inhibitors could significantly impact patient outcomes in Wnt-driven pathologies.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K